These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27077125)

  • 1. Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin.
    Foley JH; Walton BL; Aleman MM; O'Byrne AM; Lei V; Harrasser M; Foley KA; Wolberg AS; Conway EM
    EBioMedicine; 2016 Mar; 5():175-82. PubMed ID: 27077125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo-generated thrombin and plasmin do not activate the complement system in baboons.
    Keshari RS; Silasi R; Lupu C; Taylor FB; Lupu F
    Blood; 2017 Dec; 130(24):2678-2681. PubMed ID: 29021229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between the coagulation and complement system.
    Amara U; Rittirsch D; Flierl M; Bruckner U; Klos A; Gebhard F; Lambris JD; Huber-Lang M
    Adv Exp Med Biol; 2008; 632():71-9. PubMed ID: 19025115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.
    Shao Z; Nishimura T; Leung LL; Morser J
    J Thromb Haemost; 2015 Jun; 13(6):1090-102. PubMed ID: 25851247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct delivery of plasmin using clot-anchoring thrombin-responsive nanoparticles for targeted fibrinolytic therapy.
    Sun M; Hao Pontius MH; Yang S; Pendekanti T; Raghunathan S; Shavit JA; Sen Gupta A
    J Thromb Haemost; 2023 Apr; 21(4):983-994. PubMed ID: 36696210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin activity and complement activation during storage of citrated platelet concentrates.
    Bode AP; Miller DT; Newman SL; Castellani WJ; Norris HT
    J Lab Clin Med; 1989 Jan; 113(1):94-102. PubMed ID: 2521240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food intake regulation by central complement system.
    Ohinata K; Yoshikawa M
    Adv Exp Med Biol; 2008; 632():35-46. PubMed ID: 19025112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
    Rinder CS; Rinder HM; Smith BR; Fitch JC; Smith MJ; Tracey JB; Matis LA; Squinto SP; Rollins SA
    J Clin Invest; 1995 Sep; 96(3):1564-72. PubMed ID: 7657827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats.
    Lillegard KE; Loeks-Johnson AC; Opacich JW; Peterson JM; Bauer AJ; Elmquist BJ; Regal RR; Gilbert JS; Regal JF
    J Pharmacol Exp Ther; 2014 Nov; 351(2):344-51. PubMed ID: 25150279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular intercommunication between the complement and coagulation systems.
    Amara U; Flierl MA; Rittirsch D; Klos A; Chen H; Acker B; Brückner UB; Nilsson B; Gebhard F; Lambris JD; Huber-Lang M
    J Immunol; 2010 Nov; 185(9):5628-36. PubMed ID: 20870944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway.
    Krisinger MJ; Goebeler V; Lu Z; Meixner SC; Myles T; Pryzdial EL; Conway EM
    Blood; 2012 Aug; 120(8):1717-25. PubMed ID: 22802338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-antithrombin III and plasmin-antiplasmin complexes as indicators of in vivo activation of the coagulation and/or fibrinolytic systems.
    Collen D
    Acta Clin Belg; 1977; 32(6):398-402. PubMed ID: 151470
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of C5a in the absence of C3: a new complement activation pathway.
    Huber-Lang M; Sarma JV; Zetoune FS; Rittirsch D; Neff TA; McGuire SR; Lambris JD; Warner RL; Flierl MA; Hoesel LM; Gebhard F; Younger JG; Drouin SM; Wetsel RA; Ward PA
    Nat Med; 2006 Jun; 12(6):682-7. PubMed ID: 16715088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).
    Grosso G; Vikerfors A; Woodhams B; Adam M; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Svenungsson E; Antovic A
    Thromb Res; 2017 Oct; 158():168-173. PubMed ID: 28669410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation during sepsis in humans.
    Schreiber H; Rittirsch D; Flierl M; Brueckner U; Schneider M; Weiss M; Gebhard F; Huber-Lang M
    Adv Exp Med Biol; 2006; 586():217-26. PubMed ID: 16893075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.